2018
DOI: 10.1002/ccr3.1866
|View full text |Cite
|
Sign up to set email alerts
|

Case report of granular acute lymphoblastic leukemia and review of the literature

Abstract: Key Clinical MessageGranular acute lymphoblastic leukemia (ALL) is a rare variant of the disease that is associated with a lower remission rate to standard induction chemotherapy. Flow immunophenotyping, cytogenetics, and molecular diagnostics should be utilized to confirm the diagnosis of ALL versus acute myeloid leukemia (AML) in order to provide appropriate management.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…Granular ALL is defined by more than 5% marrow blasts having at least three azurophilic cytoplasmic granules. The Pediatric Oncology Group study also found that granular ALL was more frequent amongst FAB L2 compared to FAB L1 and that those with granular lymphoblasts had a significantly lower complete remission rate and event free survival [6] .…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…Granular ALL is defined by more than 5% marrow blasts having at least three azurophilic cytoplasmic granules. The Pediatric Oncology Group study also found that granular ALL was more frequent amongst FAB L2 compared to FAB L1 and that those with granular lymphoblasts had a significantly lower complete remission rate and event free survival [6] .…”
Section: Discussionmentioning
confidence: 94%
“…Diagnostic confusion may arise in ALL with cytoplasmic granular inclusions resembling that of AML. It is important to confirm the type of acute leukemia with flow cytometric immunophenotyping in all cases [6] .…”
Section: Discussionmentioning
confidence: 99%